test

Novavax COVID vaccine surprisingly effective against all Omicron variants

By Rich Haridy, newatlas, June 29, 2022 …July 03, 2022

Biotech company Novavax has revealed its COVID-19 vaccine can generate effective immune responses against all circulating Omicron variants. The unexpected data was delivered to an advisory panel convened by the US Food and Drug Administration (FDA) to recommend booster vaccine plans for later this year.

https://telegra.ph/Novavax-COVID-vaccine-surprisingly-effective-against-all-Omicron-variants-07-03

Long COVID patients show abnormal immune activity 8 months post infection

A comprehensive new study published in the journal Nature Immunology has reported immune dysregulation persists in long COVID patients up to eight months after initial infection. The Australian research found long COVID is characterized by elevated levels of specific immune biomarkers, offering the strongest objective evidence to date of this emerging chronic disease. However, researchers indicate it is still unclear what impact vaccination or the Omicron variant will have on long COVID.

https://telegra.ph/Long-COVID-patients-show-abnormal-immune-activity-8-months-post-infection-01-18